233 related articles for article (PubMed ID: 34691358)
1. THAP9-AS1 Promotes Tumorigenesis and Reduces ROS Generation through the JAK2/STAT3 Signaling Pathway by Increasing SOCS3 Promoter Methylation in Osteosarcoma.
Yang S; Wang B; Liu C; Wang Q; Wang R; Su W; Zhu Y; Li M; Guo Z; Wu X; Chen F
Oxid Med Cell Longev; 2021; 2021():5620475. PubMed ID: 34691358
[TBL] [Abstract][Full Text] [Related]
2. miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis.
Liu W; Long Q; Zhang W; Zeng D; Hu B; Liu S; Chen L
Aging (Albany NY); 2021 Aug; 13(15):19760-19775. PubMed ID: 34388111
[TBL] [Abstract][Full Text] [Related]
3. Piperlongumine inhibits the progression of osteosarcoma by downregulating the SOCS3/JAK2/STAT3 pathway via miR-30d-5p.
Hu Y; Luo X; Zhou J; Chen S; Gong M; Deng Y; Zhang H
Life Sci; 2021 Jul; 277():119501. PubMed ID: 33862108
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis.
Huang L; Hu B; Ni J; Wu J; Jiang W; Chen C; Yang L; Zeng Y; Wan R; Hu G; Wang X
J Exp Clin Cancer Res; 2016 Feb; 35():27. PubMed ID: 26847351
[TBL] [Abstract][Full Text] [Related]
5. THAP9-AS1/miR-133b/SOX4 positive feedback loop facilitates the progression of esophageal squamous cell carcinoma.
Cheng J; Ma H; Yan M; Xing W
Cell Death Dis; 2021 Apr; 12(4):401. PubMed ID: 33854048
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation and expression of SOCS3 affect the clinical outcome of pediatric acute lymphoblastic leukemia by JAK/STAT pathway.
Liu K; Wu Z; Chu J; Yang L; Wang N
Biomed Pharmacother; 2019 Jul; 115():108913. PubMed ID: 31054507
[TBL] [Abstract][Full Text] [Related]
7. Nephrotoxicity instead of immunotoxicity of OTA is induced through DNMT1-dependent activation of JAK2/STAT3 signaling pathway by targeting SOCS3.
Gan F; Zhou X; Zhou Y; Hou L; Chen X; Pan C; Huang K
Arch Toxicol; 2019 Apr; 93(4):1067-1082. PubMed ID: 30923867
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of SOCS3 overexpression in high glucose‑induced lung epithelial cell injury through the JAK2/STAT3 pathway.
Duan WN; Xia ZY; Liu M; Sun Q; Lei SQ; Wu XJ; Meng QT; Leng Y
Mol Med Rep; 2017 Sep; 16(3):2668-2674. PubMed ID: 28713982
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
[TBL] [Abstract][Full Text] [Related]
10. m
Wu R; Liu Y; Zhao Y; Bi Z; Yao Y; Liu Q; Wang F; Wang Y; Wang X
Cell Death Dis; 2019 Feb; 10(3):171. PubMed ID: 30787270
[TBL] [Abstract][Full Text] [Related]
11. LncRNA THAP9-AS1 highly expressed in tissues of hepatocellular carcinoma and accelerates tumor cell proliferation.
Su Y; Xie R; Xu Q
Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102025. PubMed ID: 36170961
[TBL] [Abstract][Full Text] [Related]
12. ROS‑mediated hypomethylation of PRDX5 promotes STAT3 binding and activates the Nrf2 signaling pathway in NSCLC.
Cao X; Chen XM; Xiao WZ; Li B; Zhang B; Wu Q; Xue Q
Int J Mol Med; 2021 Feb; 47(2):573-582. PubMed ID: 33416106
[TBL] [Abstract][Full Text] [Related]
13. MiR-203 regulates JAK-STAT pathway in affecting pancreatic cancer cells proliferation and apoptosis by targeting SOCS3.
Lin XM; Chen H; Zhan XL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6906-6913. PubMed ID: 31486490
[TBL] [Abstract][Full Text] [Related]
14. MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway.
Li XD; Li XM; Gu JW; Sun XC
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5153-5159. PubMed ID: 29228427
[TBL] [Abstract][Full Text] [Related]
15. SPTBN1 suppresses the progression of epithelial ovarian cancer via SOCS3-mediated blockade of the JAK/STAT3 signaling pathway.
Chen M; Zeng J; Chen S; Li J; Wu H; Dong X; Lei Y; Zhi X; Yao L
Aging (Albany NY); 2020 Jun; 12(11):10896-10911. PubMed ID: 32516133
[TBL] [Abstract][Full Text] [Related]
16. LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway.
Shi D; Wu F; Mu S; Hu B; Zhong B; Gao F; Qing X; Liu J; Zhang Z; Shao Z
J Exp Clin Cancer Res; 2019 Aug; 38(1):375. PubMed ID: 31443665
[TBL] [Abstract][Full Text] [Related]
17. Liensinine Inhibits Osteosarcoma Growth by ROS-Mediated Suppression of the JAK2/STAT3 Signaling Pathway.
Jia F; Liu Y; Dou X; Du C; Mao T; Liu X
Oxid Med Cell Longev; 2022; 2022():8245614. PubMed ID: 35116094
[TBL] [Abstract][Full Text] [Related]
18. MiR-340 affects gastric cancer cell proliferation, cycle, and apoptosis through regulating SOCS3/JAK-STAT signaling pathway.
Xiao C; Hong H; Yu H; Yuan J; Guo C; Cao H; Li W
Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):278-283. PubMed ID: 29658372
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of JAK2/STAT3/SOCS3 signaling attenuates atherosclerosis in rabbit.
Yang X; Jia J; Yu Z; Duanmu Z; He H; Chen S; Qu C
BMC Cardiovasc Disord; 2020 Mar; 20(1):133. PubMed ID: 32169038
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of suppressor of cytokine signaling 3 on inflammatory cytokine expression and migration and proliferation of IL-6/IFN-γ-induced vascular smooth muscle cells.
Xiang S; Dong NG; Liu JP; Wang Y; Shi JW; Wei ZJ; Hu XJ; Gong L
J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):615-622. PubMed ID: 24142708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]